Literature DB >> 10907114

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.

N Gervaise1, M A Garrigue, G Lasfargues, P Lecomte.   

Abstract

AIMS/HYPOTHESIS: Cardiovascular complications and particularly coronary heart disease are the main causes of morbidity and mortality in Type II (non-insulin-dependent) diabetes mellitus. Some studies have shown that hypertriglyceridaemia in diabetes is an independent cardiovascular risk factor. In the ECTIM study high apolipoprotein C3 and lipoprotein B:C3 concentrations (lipoparticles playing a role in triglyceride metabolism) were associated with myocardial infarction in non-diabetic subjects.
METHODS: We studied the relations between macroangiopathy and different cardiovascular risk factors and lipid variables in 188 Type II diabetic subjects.
RESULTS: Multivariate analysis showed that triglycerides, apo C3 and Lp B:C3, sex, duration of diabetes, microalbuminuria and age were independently associated with macroangiopathy. The study group was divided into quartiles according to apo C3 and Lp B:C3 concentrations: the prevalence of macroangiopathy and coronary heart disease were increased in upper quartiles. CONCLUSION/
INTERPRETATION: Triglycerides apo C3 and Lp B:C3 were independent cardiovascular risk markers in our group of Type II diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10907114     DOI: 10.1007/s001250051366

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.

Authors:  Helen C Looker; Marco Colombo; Felix Agakov; Tanja Zeller; Leif Groop; Barbara Thorand; Colin N Palmer; Anders Hamsten; Ulf de Faire; Everson Nogoceke; Shona J Livingstone; Veikko Salomaa; Karin Leander; Nicola Barbarini; Riccardo Bellazzi; Natalie van Zuydam; Paul M McKeigue; Helen M Colhoun
Journal:  Diabetologia       Date:  2015-03-05       Impact factor: 10.122

2.  Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.

Authors:  Arman Qamar; Sumeet A Khetarpal; Amit V Khera; Atif Qasim; Daniel J Rader; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-11       Impact factor: 8.311

3.  Ethnicity differences in plasma apoC-III levels between African American and Caucasian youths.

Authors:  Ji-Young Lee; Hye-Ryun Hong; Hyun-Sik Kang
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

4.  Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.

Authors:  Arpita Basu; Ionut Bebu; Alicia J Jenkins; Julie A Stoner; Ying Zhang; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Matthew J Budoff; Petar Alaupovic; Timothy J Lyons
Journal:  J Lipid Res       Date:  2019-06-15       Impact factor: 5.922

5.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Authors:  Anne Hiukka; Jamila Fruchart-Najib; Eeva Leinonen; Hannele Hilden; Jean-Charles Fruchart; Marja-Riitta Taskinen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

6.  The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patients.

Authors:  E S Nakou; T D Filippatos; A P Agouridis; C Kostara; E T Bairaktari; M S Elisaf
Journal:  Lipids       Date:  2010-04-09       Impact factor: 1.880

Review 7.  The role of non-LDL:non-HDL particles in atherosclerosis.

Authors:  Jere P Segrest
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics.

Authors:  Caren E Smith; Katherine L Tucker; Tammy M Scott; Maria Van Rompay; Josiemer Mattei; Chao-Qiang Lai; Laurence D Parnell; Mireia Junyent; Yu-Chi Lee; Bibiana Garcia-Bailo; José M Ordovás
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

Review 9.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

10.  Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.

Authors:  Wenyu Wang; Sohail Khan; Piers Blackett; Petar Alaupovic; Elisa Lee
Journal:  J Clin Lipidol       Date:  2012-07-02       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.